André Abdo

1.4k citations
24 papers · 909 · 3 hit papers · h-index 10

Impact in

  • Hematology top 5%
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
  • Physiology top 5%
    • Histiocytic Disorders and Treatments

Papers in

    • Chronic Myeloid Leukemia Treatments 9
    • Multiple Myeloma Research and Treatments 2
    • Histiocytic Disorders and Treatments 6

André Abdo

23 papers receiving 891 citations

André Abdo's Hit Papers

Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL 2023 · 104 citations
1040+2+4Years since publication50100150200250

Peers

André Abdo
Comparison fields: 5 of 52
  • Hematology 369
  • Physiology 300
  • Cardiology and Cardiovascular Medicine 78
  • Oncology 48
  • Genetics 16
Replace Cassandra Slader with:
Cassandra Slader Australia
Michaela Schwarz Germany
Noortje Thielen Netherlands
Kuolung Hu United States
Pedro Enrique Dorlhiac‐Llacer Brazil
Carella Am Italy
Takuto Miyagishima Japan
Camila C.G. Linardi Brazil
Hideyuki Koharazawa Japan
Linde M. Morsink Netherlands
André Abdo relative to Cassandra Slader Australia Cassandra Slader's profile →
Citations per field
00.5×2×4×6×8.7×
Cassandra Slader · 1×
Citations per year

Countries citing papers authored by André Abdo

Since Specialization
Citations

This map shows the geographic impact of André Abdo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Abdo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Abdo more than expected).

Fields of papers citing papers by André Abdo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Abdo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Abdo. The network helps show where André Abdo may publish in the future.

Co-authors

The 25 scholars most cited alongside André Abdo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with André Abdo Line = papers co-authored together André Abdo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
Hit paper breakdown →
2020263
2
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs
Hit paper breakdown →
2021242
3
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL
Hit paper breakdown →
2023104
4 201078
5 202053
6 201848
7 202026
8 202021
9 201612
10 201611
11 202010
12 20206
13 20216
14 20185
15 20225
16 20225
17 20203
18 20202
19 20212
20 20212

About André Abdo

André Abdo is a scholar working on Hematology, Physiology, Cardiology and Cardiovascular Medicine, Oncology and Nephrology, having authored 24 papers that have together received 909 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (9 papers), Histiocytic Disorders and Treatments (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Multiple Myeloma Research and Treatments (2 papers), Pericarditis and Cardiac Tamponade (1 paper), Blood Pressure and Hypertension Studies (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and COVID-19 and healthcare impacts (1 paper). The work is most often cited by research in Hematology (369 citations), Physiology (300 citations), Cardiology and Cardiovascular Medicine (78 citations), Oncology (48 citations) and Genetics (16 citations). André Abdo has collaborated with scholars based in Brazil, South Korea and Canada. Frequent co-authors include Juan Carlos Yugar‐Toledo, José Fernando Vilela-Martin, Vanderson Rocha, Valérie Taly, Jean‐François Emile, Julien Haroche, Frédéric Charlotte, Giancarlo Fatobene, Zofia Hélias‐Rodzewicz and Juliana C. Pereira. Their work appears in journals such as Blood, The Lancet Oncology, American Journal of Hematology, HemaSphere and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact